Clinical Characteristics of Neovascular Glaucoma
1 other identifier
observational
400
1 country
1
Brief Summary
The goal of this observational study is to explore the clinical characteristics of patients with neovascular glaucoma (NVG), and to analyze the relationship between NVG and various underlying diseases, ocular conditions, lifestyle, inflammatory markers, and treatment response. To systematically analyze the clinical data of NVG patients with different types of primary disease, further reveal the different clinical characteristics of NVG patients with different primary disease, and describe the selection of treatment methods in recent years, in order to provide more scientific basis for clinical treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedFirst Submitted
Initial submission to the registry
September 10, 2025
CompletedFirst Posted
Study publicly available on registry
September 17, 2025
CompletedSeptember 17, 2025
September 1, 2025
6.7 years
September 10, 2025
September 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
visual acuity
best-corrected visual acuity (BCVA)
Time Frame: Pre-operative, post-operative follow-up at 1 month, 3 months, 6 months, 1 year, etc.
intraocular pressure
intraocular pressure(IOP)
Time Frame: Pre-operative, post-operative follow-up at 1 month, 3 months, 6 months, 1 year, etc.
Study Arms (3)
ALL group
DR group
RVO group
Eligibility Criteria
Patients with NVG diagnosed by ophthalmic examination in the Second Clinical Hospital of Wuhan University, Central Hospital of Enshi Tujia and Miao Autonomous Prefecturefrom and Central Hospital of Xiaogan from January 2018 to September 2024 were enrolled. A certain number of healthy volunteers in the Physical Examination Center of the Second Clinical Hospital of Wuhan University from January 2018 to September 2024 were enrolled
You may qualify if:
- Patients who met the diagnostic criteria for NVG.
You may not qualify if:
- Patients with incomplete clinical data and information.
- Severe systemic diseases (such as chronic renal failure requiring dialysis, severe neurological diseases, immune diseases), pregnancy or lactation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zhongnan Hospitallead
- The Central Hospital of Enshi Tujia And Miao Autonomous Prefecturecollaborator
- Central Hospital of Xiaogancollaborator
Study Sites (1)
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, 430071, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 10, 2025
First Posted
September 17, 2025
Study Start
January 1, 2018
Primary Completion
September 1, 2024
Study Completion
September 1, 2024
Last Updated
September 17, 2025
Record last verified: 2025-09